Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mind-Controlled therapy could help restore smiles in facial palsy patients

NCT ID NCT07327710

ENROLLING_BY_INVITATION Disease control Sponsor: Nanjing Medical University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a non-invasive brain-computer interface combined with mild electrical brain stimulation can improve facial movement in people with peripheral facial palsy. Thirty adults aged 18-70 with moderate to severe facial weakness will receive up to 20 sessions over 4 weeks. The goal is to see if this technology is safe and helps restore facial symmetry and muscle control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
non-invasive brain-computer interface combined with transcranial direct current stimulation
What this could lead to
If it works, this could offer a new, drug-free way to help people with facial palsy regain better control of their facial muscles.
What could go wrong
This is a very small, early-stage trial with only 30 participants, so results may not apply to everyone. Side effects like skin tingling, fatigue, or headache are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN COMPUTER INTERFACE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bell's palsy facial nerve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN COMPUTER INTERFACE PERIPHERAL FACIAL PALSY PULSED RADIOFREQUENCY TRANSCRANIAL DIRECT CURRENT STIMULATION

Contacts and locations

Locations

  • The Second Peoples's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University

    Changzhou, Jiangsu, 213000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.